Cyclooxygenases and prostaglandins: shaping up the immune response (Q34639775)

3 August 2017

1 reference

title

Cyclooxygenases and prostaglandins: shaping up the immune response (English)

1 reference

3 August 2017

Bianca Rocca

1

1 reference

PubMed ID

12013502

3 August 2017

Garret A FitzGerald

series ordinal

2

1 reference

3 August 2017

1 April 2002

1 reference

International Immunopharmacology

3 August 2017

1 reference

3 August 2017

2

1 reference

3 August 2017

5

1 reference

3 August 2017

603-630

1 reference

Why there are two cyclooxygenase isozymes

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

COX in a crystal ball: current status and future promise of prostaglandin research

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Distinct roles of prostaglandin H synthases 1 and 2 in T-cell development

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

NF-kappaB: a key role in inflammatory diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Genetic and pharmacological analysis of prostanoid receptor function

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

The coxibs, selective inhibitors of cyclooxygenase-2.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Inhibition of NF-kappa B by sodium salicylate and aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Inhibition of activator protein 1 activity and neoplastic transformation by aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Subversion of immune system by tumor cells and role of prostaglandins

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Suppression of human T-cell mitogenesis by prostaglandin. Existence of a prostaglandin-producing suppressor cell

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

The immune system. First of two parts

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

The immune system. Second of two parts

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

T-Cell Function and Migration — Two Sides of the Same Coin

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Crossregulation Between Th1 and Th2 Cells

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Thromboxane generation by human peripheral blood polymorphonuclear leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Release of prostaglandins from human polymorphonuclear leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Cytokine-stimulation of prostaglandin synthesis from endogenous and exogenous arachidonic acids in polymorphonuclear leukocytes involving activation and new synthesis of cyclooxygenase

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Expression and activity of prostaglandin endoperoxide synthase-2 in agonist-activated human neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Induction of cytosolic phospholipase A2 and prostaglandin H2 synthase-2 by lipopolysaccharide in human polymorphonuclear leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Human neutrophils express the prostaglandin G/H synthase 2 gene when stimulated with bacterial lipopolysaccharide.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Effect of regulated expression of human cyclooxygenase isoforms on eicosanoid and isoeicosanoid production in inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Granulocyte colony-stimulating factor induction of improved leukocytopenia with inflammatory flare in a Felty's syndrome patient

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Reactivation of rheumatoid arthritis and development of leukocytoclastic vasculitis in a patient receiving granulocyte colony-stimulating factor for Felty's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Dendritic cells and the control of immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Development of Th1-inducing capacity in myeloid dendritic cells requires environmental instruction

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Effect of interleukin-10 on dendritic cell maturation and function

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Prostaglandin E2 and tumor necrosis factor alpha cooperate to activate human dendritic cells: synergistic activation of interleukin 12 production

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Autoregulation of human monocyte-derived dendritic cell maturation and IL-12 production by cyclooxygenase-2-mediated prostanoid production

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Comparative studies of adherent rheumatoid synovial cells in primary culture: characterisation of the dendritic (stellate) cell

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Chemokines: a new classification system and their role in immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Prostaglandin E2 up-regulates macrophage-derived chemokine production but suppresses IFN-inducible protein-10 production by APC.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Langerhans cells as macrophages in skin and lymphoid organs

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Cyclooxygenase-independent inhibition of dendritic cell maturation by aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Dendritic cells and monocytes as accessory cells in T-cell responses in man. II. Function as antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Evidence for involvement of NF-kappaB in the transcriptional control of COX-2 gene expression by IL-1beta

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Dissociation of basal turnover and cytokine-induced transcript stabilization of the human cyclooxygenase-2 mRNA by mutagenesis of the 3'-untranslated region

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Transcriptional roles of nuclear factor kappa B and nuclear factor-interleukin-6 in the tumor necrosis factor alpha-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Involvement of nuclear factor kappa B in the regulation of cyclooxygenase-2 expression by interleukin-1 in rheumatoid synoviocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Involvement of NF-kappaB in the regulation of cyclooxygenase-2 protein expression in LPS-stimulated J774 macrophages.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Transcriptional role of the nuclear factor kappa B site in the induction by lipopolysaccharide and suppression by dexamethasone of cyclooxygenase-2 in U937 cells

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Regulation of prostaglandin H synthase 2 expression in human monocytes by the marine natural products manoalide and scalaradial. Novel effects independent of inhibition of lipid mediator production

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Differential regulation of cyclooxygenase-2 (COX-2) mRNA stability by interleukin-1 beta (IL-1 beta) and tumor necrosis factor-alpha (TNF-alpha) in human in vitro differentiated macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Il-10 is a central regulator of cyclooxygenase-2 expression and prostaglandin production.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Macrophages in human atheroma contain PPARgamma: differentiation-dependent peroxisomal proliferator-activated receptor gamma(PPARgamma) expression and reduction of MMP-9 activity through PPARgamma activation in mononuclear phagocytes in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Differential activation of peroxisome proliferator-activated receptors by eicosanoids.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Prostaglandins modulate macrophage Ia expression

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Species-dependent regulation of monocyte/macrophage Ia antigen expression and antigen presentation by prostaglandin E

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Regulation of natural killer cell activity by transforming growth factor-beta and prostaglandin E2

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Inhibition of human NK cell and LAK cell cytotoxicity and differentiation by PGE2.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Inhibition of murine lymphokine-activated killer (LAK) cell activity by adherent cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

A possible role of prostaglandins in the inhibition of natural and antibody-dependent cell-mediated cytotoxicity against tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Suppression of lymphocyte alloreactivity by early gestational human decidua. II. Characterization of the suppressor mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

PGE2-mediated immunosuppression by first trimester human decidual cells blocks activation of maternal leukocytes in the decidua with potential anti-trophoblast activity

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Prostaglandin-mediated inactivation of natural killer cells in the murine decidua

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Immunocytochemical demonstration of prostaglandin synthase (cyclooxygenase) in thymic macrophages of normal and cyclosporin-treated rats

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Expression of prostaglandin G/H synthase (cyclooxygenase) during murine fetal thymic development

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Localization of thromboxane synthase in human tissues by monoclonal antibody Tü 300

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

In situ hybridization studies of prostacyclin receptor mRNA expression in various mouse organs

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

RAG-1-deficient mice have no mature B and T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Constitutive Bcl-2 expression throughout the hematopoietic compartment affects multiple lineages and enhances progenitor cell survival

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Positive selection of thymocytes: the long and winding road.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Thymic stromal cell specialization and the T-cell receptor repertoire

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Differential eicosanoid synthesis by murine fetal thymic non-lymphoid cells

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Thymocytes stimulate metabolism of arachidonic acid in rat thymic epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins, and mitogenesis in polarizing colon cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Regulation of cyclooxygenase-2 by interferon gamma and transforming growth factor alpha in normal human epidermal keratinocytes and squamous carcinoma cells. Role of mitogen-activated protein kinases

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Interferon gamma induces prostaglandin G/H synthase-2 through an autocrine loop via the epidermal growth factor receptor in human bronchial epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Selective events in T cell development

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Thromboxane A2 receptor is highly expressed in mouse immature thymocytes and mediates DNA fragmentation and apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Coagulation defects and altered hemodynamic responses in mice lacking receptors for thromboxane A2

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Structure and expression of the murine thromboxane A2 receptor gene

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Eicosanoid metabolism by lymphocytes: do all human nucleated cells generate eicosanoids?

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

In vitro synthesis of prostaglandins and related lipids by populations of human peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Role of lipoxygenase metabolites of arachidonic acid in T cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Release of arachidonic acid metabolites by human monocytes or lymphocytes: effect of treatment with interferon on stimulation by phorbol ester or calcium ionophore

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Cyclooxygenase-1 and -2 are expressed by human T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Prostaglandin inhibition of T-cell proliferation is mediated at two levels

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Analysis of prostaglandin E2 effect on T lymphocyte activation. Abrogation of prostaglandin E2 inhibitory effect by the tumor promotor 12.0 tetradecanoyl phorbol-13 acetate

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Prostaglandin E inhibits the production of human interleukin 2

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Regulation of the immune response by prostaglandins

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Effect of nonsteroidal antiinflammatory drugs on immune function

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

In vitro and in vivo activated T cells display increased sensitivity to PGE2.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

An EP receptor with a novel pharmacological profile in the T‐cell line Jurkat

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Effects of prostaglandin E2 on Th0-type human T cell clones: modulation of functions of nuclear proteins involved in cytokine production

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Receptors for prostaglandin E(2) that regulate cellular immune responses in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

An Essential Role of the Nuclear Factor of Activated T Cells in the Regulation of the Expression of the Cyclooxygenase-2 Gene in Human T Lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Prostaglandin E2 biphasic control of lymphocyte proliferation: inhibition by picomolar concentrations.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Prostaglandin E2 primes naive T cells for the production of anti-inflammatory cytokines.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Differential modulation of T helper type 1 (Th1) and T helper type 2 (Th2) cytokine secretion by prostaglandin E2 critically depends on interleukin-2.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Accessory cell-derived interleukin-12 and prostaglandin E2 determine the level of interferon-gamma produced by activated human CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Exclusive expression of the Gs-linked prostaglandin E2 receptor subtype 4 mRNA in mononuclear Jurkat and KM-3 cells and coexpression of subtype 4 and 2 mRNA in U-937 cells

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Sensitivity difference to the suppressive effect of prostaglandin E2 among mouse strains: a possible mechanism to polarize Th2 type response in BALB/c mice

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Diverse expression of cytosolic phospholipase A2, 5-lipoxygenase and prostaglandin H synthase 2 in acute pre-B-lymphocytic leukaemia cells

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Characterization and regulation of prostaglandin E2 receptors on normal and malignant murine B lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

A molecular analysis of PGE receptor (EP) expression on normal and transformed B lymphocytes: coexpression of EP1, EP2, EP3beta and EP4.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Prostaglandin E2 induces apoptosis in immature normal and malignant B lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Prostaglandin E2 receptors of the EP2 and EP4 subtypes regulate activation and differentiation of mouse B lymphocytes to IgE-secreting cells

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

A new view of prostaglandin E regulation of the immune response.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Prostaglandin E(2) and stem cell factor can deliver opposing signals to B lymphocyte precursors

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Regulation of human B cell activation by prostaglandin E2. Suppression of the generation of immunoglobulin-secreting cells

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Interference with tolerance induction in vivo by inhibitors of prostaglandin synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Prostaglandin E2 promotes the induction of anergy during T helper cell recognition of myelin basic protein

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4,

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

The protective effects of omega-6 fatty acids in experimental autoimmune encephalomyelitis (EAE) in relation to transforming growth factor-beta 1 (TGF-beta1) up-regulation and increased prostaglandin E2 (PGE2) production

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

IL-4 is a differentiation factor for transforming growth factor-beta secreting Th3 cells and oral administration of IL-4 enhances oral tolerance in experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

COX-2: promoting tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Cyclooxygenase-2-dependent arachidonic acid metabolites are essential modulators of the intestinal immune response to dietary antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Spontaneous and continuous cyclooxygenase-2-dependent prostaglandin E2 production by stromal cells in the murine small intestine lamina propria: directing the tone of the intestinal immune response

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Regulation by prostaglandin E2 of interleukin release by T lymphocytes in mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Th1 to Th2 cytokine shifts in nonobese diabetic mice: sometimes an outcome, rather than the cause, of diabetes resistance elicited by immunostimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

The third function of the thymus.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Aberrant prostaglandin synthase 2 expression defines an antigen-presenting cell defect for insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Suppression of S-Antigen-induced Experimental Autoimmune Uveoretinitis in Lewis Rats by Oral Administration with CGS-13080, A Thromboxane Synthetase Inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Sodium butyrate upregulates Kupffer cell PGE2 production and modulates immune function

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Mycophenolate Mofetil Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

A prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone, and mycophenolate mofetil in primary adult liver transplant recipients: an interim report

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Mycophenolate mofetil decreases endothelial prostaglandin E2 in response to allogeneic T cells or cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Thromboxane A2 receptor blocking abrogates donor-specific unresponsiveness to renal allografts induced by thymic recognition of major histocompatibility allopeptides

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Thromboxane augmentation of alloreactive T cell function

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

The host-tumor immune conflict: from immunosuppression to resistance and destruction

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Prognostic significance of cyclooxygenase-2 in laryngeal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Contribution of monocytes to the decreased lymphoproliferative response to phytohemagglutinin in patients with lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Indomethacin sensitive suppressor-cell activity in head and neck cancer patients. The role of the adherent mononuclear cell

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Monocytes from mobilized stem cells inhibit T cell function

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Elevated prostaglandin E2 production by monocytes is responsible for the depressed levels of natural killer and lymphokine-activated killer cell function in patients with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Prostaglandin-Producing Suppressor Cells in Hodgkin's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Atopy and asthma: genetic variants of IL-4 and IL-13 signalling

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Hypothesis: decreased use of pediatric aspirin has contributed to the increasing prevalence of childhood asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Eicosanoids in skin of patients with atopic dermatitis: prostaglandin E2 and leukotriene B4 are present in biologically active concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Monocyte derived IL 10 and PGE2 are associated with the absence of Th 1 cells and in vitro T cell suppression in lepromatous leprosy

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Depressed lymphocyte transformation and the role of prostaglandins in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Enhanced prostaglandin E2 production by monocytes in atopic dermatitis (AD) is not accompanied by enhanced production of IL-6, IL-10 or IL-12.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

gamma-interferon production in atopic dermatitis shows differential modification by phosphodiesterase and prostaglandin inhibition.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Prostaglandin E2 control of T cell cytokine production is functionally related to the reduced lymphocyte proliferation in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

High Affinity IgE Receptor-Mediated Prostaglandin E2 Production by Monocytes in Atopic Dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Impaired antibody responses in the hyperimmunoglobulin E syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Therapeutic strategies for allergic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Prostaglandin E(2) increases bovine leukemia virus tax and pol mRNA levels via cyclooxygenase 2: regulation by interleukin-2, interleukin-10, and bovine leukemia virus

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

HIV-induced TNF-alpha regulates arachidonic acid and PGE2 release from HIV-infected mononuclear phagocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Increased PGE2 production mediates the in vitro inhibitory effect of the human immunodeficiency virus P24 immunosuppressive heptapeptide Ch7.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Soluble factor of transformed B lymphocytes in patients with HIV infection stimulates monocytes to produce PGE2.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Correlation between induction of lymphocyte apoptosis and prostaglandin E2 production by macrophages infected with HIV

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Human immunodeficiency virus glycoprotein (gp120) induction of monocyte arachidonic acid metabolites and interleukin 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Human immunodeficiency virus type 1 envelope protein does not stimulate either prostaglandin formation or the expression of prostaglandin H synthase in THP-1 human monocytes/macrophages.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Prostaglandin E2 Up-regulates HIV-1 long terminal repeat-driven gene activity in T cells via NF-kappaB-dependent and -independent signaling pathways

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Elevated central nervous system prostaglandins in human immunodeficiency virus-associated dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Oral prostaglandin (PGE2) therapy for chronic viral hepatitis B and C.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900204-1

7 January 2021

10.1016/S1567-5769(01)00204-1

Identifiers

DOI

1 reference

3 August 2017

1 reference

PubMed ID

12013502